TY - JOUR
T1 - Prognostic Utility of the Glasgow Prognostic Score for the Long-Term Outcomes After Liver Resection for Intrahepatic Cholangiocarcinoma
T2 - A Multi-institutional Study
AU - Sui, Kenta
AU - Okabayashi, Takehiro
AU - Umeda, Yuzo
AU - Oishi, Masahiro
AU - Kojima, Toru
AU - Sato, Daisuke
AU - Endo, Yoshikatsu
AU - Ota, Tetsuya
AU - Hioki, Katsuyoshi
AU - Inagaki, Masaru
AU - Matsuda, Tadakazu
AU - Hirai, Ryuji
AU - Kimura, Masashi
AU - Yagi, Takahito
AU - Fujiwara, Toshiyoshi
N1 - Funding Information:
This study was financially supported by the Japan Society for the Promotion of Science (JSPS), Grant Number 19K09217 to Yuzo Umeda. Acknowledgements
Funding Information:
The authors thank their colleagues who contributed to data collection for this study: Kazuyasu Kobayashi (Sumitomo Besshi Hospital), Toshihiro Murata (Onomichi Municipal Hospital), Hideki Aoki (National Iwakuni Medical Center), Yasuhiko Ishida (Himeji Central Hospital), and Nobuhiro Ishido (Kobe Red Cross Hospital). The authors wish to thank Dr.?Tomokazu Fuji and Kazuhiro Yoshida for giving technical assistance.
Publisher Copyright:
© 2020, Société Internationale de Chirurgie.
PY - 2021/1
Y1 - 2021/1
N2 - Objective: The usefulness of the modified Glasgow prognostic score (GPS) as a prognostic tool remains unclear for patients undergoing curative surgery for intrahepatic cholangiocarcinoma (ICC). Therefore, this study investigated the prognostic usefulness of the GPS for patients who underwent ICC surgery. Method: All ICC patients who had a curative-intent hepatectomy at 17 institutions between 2000 and 2016 were included. The correlation was assessed between the preoperative GPS and the baseline characteristics of the patients, histopathological parameters, surgical parameters, and the postresection overall survival (OS). Result: There were 273 patients who met the eligibility criteria between the years 2000 and 2016. The postoperative OS rates at 1, 3, and 5 years were 83.8%, 56.3%, and 41.5%, respectively (median OS, 47.7 months). A multivariate analysis revealed the factors that were associated with a worse OS, which included an increased GPS (hazard ratio = 1.62; 95% confidence interval [CI]: 1.01–2.53; P = 0.03), an elevated carcinoembryonic antigen level (hazard ratio = 1.60; 95% CI: 1.06–2.41; P = 0.02), an elevated carbohydrate antigen 19–9 level (hazard ratio = 1.55; 95% CI: 1.05–2.30; P = 0.03), undifferentiated carcinoma (hazard ratio = 2.41; 95% CI: 1.56–3.67; P < 0.01), and positive metastasis to the lymph nodes (hazard ratio = 2.54; 95% CI: 1.76–3.67; P < 0.01). In ICC patients after a hepatectomy, an elevated GPS was associated with poorer OS, even if the tumour factors that affected GPS were eliminated by propensity-score matching. Conclusion: Preoperative GPS can be useful to predict the postoperative outcomes of ICC patients. Therefore, this relatively simple and inexpensive scoring system can be utilized to further refine patient stratification as well as to predict survival.
AB - Objective: The usefulness of the modified Glasgow prognostic score (GPS) as a prognostic tool remains unclear for patients undergoing curative surgery for intrahepatic cholangiocarcinoma (ICC). Therefore, this study investigated the prognostic usefulness of the GPS for patients who underwent ICC surgery. Method: All ICC patients who had a curative-intent hepatectomy at 17 institutions between 2000 and 2016 were included. The correlation was assessed between the preoperative GPS and the baseline characteristics of the patients, histopathological parameters, surgical parameters, and the postresection overall survival (OS). Result: There were 273 patients who met the eligibility criteria between the years 2000 and 2016. The postoperative OS rates at 1, 3, and 5 years were 83.8%, 56.3%, and 41.5%, respectively (median OS, 47.7 months). A multivariate analysis revealed the factors that were associated with a worse OS, which included an increased GPS (hazard ratio = 1.62; 95% confidence interval [CI]: 1.01–2.53; P = 0.03), an elevated carcinoembryonic antigen level (hazard ratio = 1.60; 95% CI: 1.06–2.41; P = 0.02), an elevated carbohydrate antigen 19–9 level (hazard ratio = 1.55; 95% CI: 1.05–2.30; P = 0.03), undifferentiated carcinoma (hazard ratio = 2.41; 95% CI: 1.56–3.67; P < 0.01), and positive metastasis to the lymph nodes (hazard ratio = 2.54; 95% CI: 1.76–3.67; P < 0.01). In ICC patients after a hepatectomy, an elevated GPS was associated with poorer OS, even if the tumour factors that affected GPS were eliminated by propensity-score matching. Conclusion: Preoperative GPS can be useful to predict the postoperative outcomes of ICC patients. Therefore, this relatively simple and inexpensive scoring system can be utilized to further refine patient stratification as well as to predict survival.
UR - http://www.scopus.com/inward/record.url?scp=85091604356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091604356&partnerID=8YFLogxK
U2 - 10.1007/s00268-020-05797-4
DO - 10.1007/s00268-020-05797-4
M3 - Article
C2 - 32989578
AN - SCOPUS:85091604356
SN - 0364-2313
VL - 45
SP - 279
EP - 290
JO - World Journal of Surgery
JF - World Journal of Surgery
IS - 1
ER -